Department of Psychiatry and Obstetrics and Gynecology, University of Massachusetts Medical School/UMass Memorial Health Care, 55 Lake Ave North, Worcester, MA, 01655, USA.
Psychiatr Q. 2013 Jun;84(2):169-74. doi: 10.1007/s11126-012-9236-0.
This is the first study evaluating obstetrics and gynecology (OB/Gyn) provider and staff perceptions of barriers to accessing pharmacotherapy for perinatal depression outside the obstetric setting. Four, 90 min focus groups were conducted with OB/Gyn physicians, advance practice nurses, and support and nursing staff (n = 28). Data were analyzed with a grounded theory approach. Participants perceived that community mental health providers and pharmacists often do not want to participate in pharmacotherapy for perinatal women. Participants believed the solution is training for community mental health providers in the risks and benefits of pharmacotherapy for perinatal depression and improved communication between OB/Gyn's and community mental health providers. Community mental health provider and pharmacist reluctance to provide pharmacotherapy hinders OB/Gyn's perceived ability to address perinatal depression. Community mental health provider and pharmacist training are needed to mitigate precipitous discontinuation of treatment and to improve access to pharmacotherapy for perinatal women.
这是第一项评估妇产科医生和工作人员对在产科环境之外获得围产期抑郁药物治疗的障碍的看法的研究。对妇产科医生、高级执业护士以及支持和护理人员（n=28）进行了四次 90 分钟的焦点小组讨论。采用扎根理论方法进行数据分析。参与者认为社区心理健康提供者和药剂师通常不愿意为围产期妇女提供药物治疗。参与者认为，解决办法是对社区心理健康提供者进行有关围产期抑郁症药物治疗的风险和益处的培训，并改善妇产科医生与社区心理健康提供者之间的沟通。社区心理健康提供者和药剂师不愿提供药物治疗，这阻碍了妇产科医生认为自己能够解决围产期抑郁问题的能力。需要对社区心理健康提供者和药剂师进行培训，以减少治疗的突然中断，并改善围产期妇女获得药物治疗的机会。
